Regionally dependent neuromuscular functions of motilin and 5-HT4 receptors in human isolated esophageal body and gastric fundus

被引:18
作者
Broad, J. [1 ]
Hughes, F. [2 ]
Chin-Aleong, J. [3 ]
Sifrim, D. [1 ]
Sanger, G. J. [1 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Neurogastroenterol Grp, London, England
[2] Royal London Hosp, Dept Upper GI Surg, London E1 1BB, England
[3] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Pathol Core Facil, London, England
基金
英国医学研究理事会;
关键词
motilin; prucalopride; 5-HT4; human; esophagus; stomach; cholinergic; GASTROESOPHAGEAL-REFLUX DISEASE; ELECTRICAL-FIELD STIMULATION; HIGH-RESOLUTION MANOMETRY; CIRCULAR SMOOTH-MUSCLE; SPHINCTER PRESSURE; ORAL ERYTHROMYCIN; ACID REFLUX; GASTROINTESTINAL MOTILITY; CHOLINERGIC NERVES; DIABETES-MELLITUS;
D O I
10.1111/nmo.12394
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Motilin agonists promote human gastric motility and cholinergic activity, but excitatory and inhibitory actions are reported in the esophagus. The effect of 5-HT4 agonists in esophagus is also unclear. Perhaps the use of drugs with additional actions explains the variation. The aim, therefore, was to examine how motilin and prucalopride, selective motilin and 5-HT4 receptor agonists, modulate neuromuscular functions in human esophagus and gastric fundus. Methods Electrical field stimulation (EFS) evoked nerve-mediated contractions of circular and longitudinal muscle from human esophageal body and circular muscle from gastric fundus. Key Results In esophageal circular muscle EFS evoked brief contraction, followed by another contraction on termination of EFS, each prevented by atropine. Nitric oxide synthase inhibition facilitated contraction during EFS and the overall contraction became monophasic. In esophagus longitudinal muscle and gastric fundus, EFS evoked cholinergically mediated, monophasic contractions, attenuated by simultaneous nitrergic activation. Motilin (100-300 nM) reduced esophagus circular muscle contractions during EFS, unaffected by L-NAME or apamin. Motilin 300 nM also reduced EFS-evoked contractions of longitudinal muscle. Similar concentrations of motilin facilitated cholinergic activity in the fundus and increased baseline muscle tension. Prucalopride facilitated EFS-evoked contractions in esophagus (tested at 30 mu M) and fundus (0.1-30 mu M). Conclusions & Inferences Selective motilin and 5-HT4 agonists have different, region-dependent abilities to modulate human esophageal and stomach neuromuscular activity, exemplified by weak inhibition (motilin) or excitation (5-HT4) in esophageal body and excitation for both in stomach. In different patients with motility dysfunctions, motilin and 5-HT4 agonists may reduce gastro-esophageal reflux in different ways.
引用
收藏
页码:1311 / 1322
页数:12
相关论文
共 69 条
[1]   Gastroesophageal reflux disease [J].
Armstrong, D .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (06) :589-595
[2]   Serotonin pharmacology in the gastrointestinal tract: a review [J].
Beattie, D. T. ;
Smith, J. A. M. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 (03) :181-203
[3]   The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound [J].
Briejer, MR ;
Bosmans, JP ;
Van Daele, P ;
Jurzak, M ;
Heylen, L ;
Leysen, JE ;
Prins, NH ;
Schuurkes, JAJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (01) :71-83
[4]   Drugs acting at 5-HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach [J].
Broad, J. ;
Goralczyk, A. ;
Mannur, K. ;
Dukes, G. E. ;
Sanger, G. J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (06) :851-861
[5]   Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility [J].
Broad, J. ;
Kung, V. W. S. ;
Boundouki, G. ;
Aziz, Q. ;
De Maeyer, J. H. ;
Knowles, C. H. ;
Sanger, G. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (06) :1253-1261
[6]   Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists [J].
Broad, J. ;
Mukherjee, S. ;
Samadi, M. ;
Martin, J. E. ;
Dukes, G. E. ;
Sanger, G. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (04) :763-774
[7]  
Broad J, 2011, P BR PHARM SOC
[8]   The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin [J].
Broad, John ;
Sanger, Gareth J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (08) :1859-1867
[9]   Delayed gastric emptying in gastroesophageal reflux disease: Reassessment with new methods and symptomatic correlations [J].
Buckles, DC ;
Sarosiek, I ;
McMillin, C ;
McCallum, RW .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 327 (01) :1-4
[10]   Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations [J].
Castell, DO ;
Murray, JA ;
Tutuian, R ;
Orlando, RC ;
Arnold, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :14-25